(8-112) LIBERTAS: Assessing the Impact of Intermittent vs. Continuous ADT via Implementation of Endpoints Derived From Digital Wearables in Patients with Castration Sensitive Prostate Cancer

Tuesday, December 9, 2025

2:00 PM - 3:30 PM

Location: Bayside A, Level 1

Fellowship Program: Rutgers Pharmaceutical Industry Fellowship Program
Fellowship Location: New Jersey

Co-Author(s): Alex Dos Santos, Ashita Batavia, Mark Wildgust, Daniel Sanchez

Primary Author(s)

Victoria Weisbrod, PharmD

Oncology Global Medical Affairs Post Doctoral Fellow
Johnson & Johnson